NCT01808534 - Palifosfamide in Treating Patients With Recurrent Germ Cell Tumors | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions

Adult Central Nervous System Germ Cell TumorAdult TeratomaMalignant Extragonadal Germ Cell TumorMalignant Extragonadal Non-Seminomatous Germ Cell TumorExtragonadal SeminomaRecurrent Malignant Testicular Germ Cell TumorRecurrent Ovarian Germ Cell TumorStage IV Extragonadal Non-Seminomatous Germ Cell TumorStage IV Extragonadal SeminomaStage IV Ovarian Germ Cell Tumor

Interventions

DRUG

palifosfamide

Given IV

Trial Locations (3)

19104

Abramson Cancer Center of The University of Pennsylvania, Philadelphia

46202

Indiana University Cancer Center, Indianapolis

98101

Virginia Mason Medical Center, Seattle